Effects of EPA and DHA on blood pressure and inflammatory factors: a meta-analysis of randomized controlled trials

• Published in: Critical reviews in food science and nutrition Vol. 59; no. 20; pp. 3380 - 3393
• Main Authors: Guo, Xiao-fei, Li, Ke-lei, Li, Jiao-mei, Li, Duo
• Format: Journal Article
• Language: English
• Published: United States Taylor & Francis 13.11.2019; Taylor & Francis Ltd
• Subjects: Blood Pressure; C-reactive protein; C-Reactive Protein - analysis; chronic diseases; Chronic illnesses; Clinical trials; Cytokines - blood; diastolic blood pressure; Dietary Supplements; Docosahexaenoic acid; Docosahexaenoic Acids - pharmacology; Dyslipidemia; Eicosapentaenoic acid; Eicosapentaenoic Acid - pharmacology; Humans; hyperlipidemia; Inflammation; Inflammatory factors; interleukin-6; Interleukins; Meta-analysis; Pressure effects; Randomization; randomized clinical trials; Randomized controlled trial; Randomized Controlled Trials as Topic; Risk analysis; Risk factors; statistical models; systolic blood pressure; tumor necrosis factor-alpha; Tumor necrosis factor-TNF; Tumor necrosis factor-α; Inflammatory factors; Blood pressure; Docosahexaenoic acid; Eicosapentaenoic acid; Randomized controlled trial

The present study aimed to clarify whether eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA) have differential effects on blood pressure and inflammatory mediators. A systematic literature search was conducted in PubMed and Scopus updated to Apr. 2018. The mean changes in risk factors of ch...